top of page
PASSRACGP Logo_white.png

Progress

0%

Cardiovascular

Sinusitis


Classification

  • Acute: <4 weeks

  • Subacute: 4–12 weeks

  • Chronic: >12 weeks (± nasal polyps)

  • Recurrent acute: ≥4 episodes/year, each <4 weeks, with full resolution between


Aetiology

  • Viral (most common): Rhinovirus, influenza, parainfluenza

  • Bacterial (<2% of viral URTIs): S. pneumoniae, H. influenzae, M. catarrhalis

  • Other: Fungal (rare, immunocompromised), allergic rhinosinusitis, anatomical abnormalities


Clinical Features

  • Typical symptoms: Nasal congestion, mucopurulent discharge, facial pain (worse bending forward), hyposmia/anosmia, postnasal drip cough, malaise, low-grade fever

  • Bacterial sinusitis indicators:

    • Symptoms >10 days without improvement

    • Severe symptoms (≥39°C, purulent discharge, facial pain) for ≥3–4 days

    • "Double worsening" (initial improvement, then worsening)


Red Flags & Complications (Urgent referral)

  • Orbital cellulitis: Eye pain, redness, proptosis, diplopia, restricted eye movements

  • Intracranial spread: Meningitis, abscess, cavernous sinus thrombosis (severe headache, altered mental state, focal neuro signs, neck stiffness)

  • Osteomyelitis: Frontal bone involvement

  • Severe pain unresponsive to treatment

  • Unilateral nasal polyp/bleeding (suspect neoplasm)


Investigations

  • Clinical diagnosis (imaging rarely needed)

  • CT sinuses if:

    • Suspicion of orbital/intracranial complications

    • Persistent/recurrent sinusitis not responding to treatment

    • Suspected neoplasm, fungal infection, anatomical abnormality

  • Nasal endoscopy (ENT) for chronic/complicated cases


Management of Acute Sinusitis

  • Supportive (first-line for viral cases):

    • Analgesia: Paracetamol, NSAIDs

    • Nasal saline irrigation

    • Intranasal corticosteroids (e.g. budesonide, fluticasone) if significant inflammation/allergy

    • Nasal decongestants (oxymetazoline/xylometazoline, max 5 days)

  • Antibiotics (per RACGP/Therapeutic Guidelines) – only if:

    • Severe symptoms (≥39°C, purulent discharge, facial pain) ≥3–4 days

    • Symptoms >10 days without improvement

    • "Double worsening"

    • High-risk patients (immunocompromised, red flags)

    First-line:

    • Amoxicillin 500 mg–1 g TDS (adults)

    • Amoxicillin + Clavulanic Acid if high risk/refractory

    • Duration: 5–7 days (adults); 10–14 days if complicated

    Penicillin allergy:

    • Mild: Cephalosporin (e.g. cefuroxime)

    • Severe (Type I hypersensitivity): Macrolide (e.g. clarithromycin) or doxycycline (adults)

  • Adjuncts:

    • Intranasal corticosteroids: May improve symptoms

    • Oral corticosteroids: Not routine; specialist-advised for severe inflammation/nasal polyps

    • Antihistamines: Only if allergic component


Management of Chronic Sinusitis

  • Long-term intranasal corticosteroids + nasal saline irrigation

  • Manage comorbidities (e.g. allergic rhinitis, asthma)

  • Intermittent antibiotics for acute exacerbations

  • Surgery (FESS) if persistent symptoms despite optimal medical therapy, complications, or anatomical obstruction


Referral Indications

  • Red flags (orbital/intracranial/bony complications)

  • No improvement or recurrent episodes despite appropriate medical therapy

  • Suspected nasal polyps or mass

  • Chronic sinusitis requiring surgery

  • Suspected immunodeficiency or unusual pathogens

Bookmark Failed!

Bookmark Saved!

bottom of page